283 related articles for article (PubMed ID: 31440050)
1. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects.
Wang Y; Cao S; Yu K; Yang F; Yu X; Zhai Y; Wu C; Xu Y
Int J Nanomedicine; 2019; 14():5849-5863. PubMed ID: 31440050
[No Abstract] [Full Text] [Related]
2. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-atopic dermatitis activities between DHMEQ and tacrolimus ointments in mouse model without stratum corneum.
He H; Gao X; Wang X; Li X; Jiang X; Xie Z; Ma K; Ma J; Umezawa K; Zhang Y
Int Immunopharmacol; 2019 Jun; 71():43-51. PubMed ID: 30877873
[TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus in the treatment of atopic dermatitis.
Gianni LM; Sulli MM
Ann Pharmacother; 2001; 35(7-8):943-6. PubMed ID: 11485148
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation.
Li G; Fan Y; Fan C; Li X; Wang X; Li M; Liu Y
Eur J Pharm Biopharm; 2012 Sep; 82(1):49-57. PubMed ID: 22705640
[TBL] [Abstract][Full Text] [Related]
6. Topical application of FK506 (tacrolimus) ointment inhibits mite antigen-induced dermatitis by local action in NC/Nga mice.
Sasakawa T; Higashi Y; Sakuma S; Hirayama Y; Sasakawa Y; Ohkubo Y; Mutoh S
Int Arch Allergy Immunol; 2004 Jan; 133(1):55-63. PubMed ID: 14726632
[TBL] [Abstract][Full Text] [Related]
7. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice.
Hiroi J; Sengoku T; Morita K; Kishi S; Sato S; Ogawa T; Tsudzuki M; Matsuda H; Wada A; Esaki K
Jpn J Pharmacol; 1998 Feb; 76(2):175-83. PubMed ID: 9541280
[TBL] [Abstract][Full Text] [Related]
8. Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis.
Seo SR; Lee SG; Lee HJ; Yoon MS; Kim DH
Acta Derm Venereol; 2017 Aug; 97(8):957-958. PubMed ID: 28512670
[No Abstract] [Full Text] [Related]
9. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y
Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children.
Alaiti S; Kang S; Fiedler VC; Ellis CN; Spurlin DV; Fader D; Ulyanov G; Gadgil SD; Tanase A; Lawrence I; Scotellaro P; Raye K; Bekersky I
J Am Acad Dermatol; 1998 Jan; 38(1):69-76. PubMed ID: 9448208
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
Rico MJ; Lawrence I
Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
[TBL] [Abstract][Full Text] [Related]
12. Topical tacrolimus: a new therapy for atopic dermatitis.
Russell JJ
Am Fam Physician; 2002 Nov; 66(10):1899-902. PubMed ID: 12469964
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
[TBL] [Abstract][Full Text] [Related]
15. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
[TBL] [Abstract][Full Text] [Related]
16. [Expression of nuclear factor kappaB and the effect of topical tacrolimus ointment on lesional atopic dermatitis skin].
Xie ZQ; Liu LL; Dou X; Wen WJ; Wang D; Zhu XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):487-90. PubMed ID: 15489928
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
Carroll CL; Fleischer AB
Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
[TBL] [Abstract][Full Text] [Related]
18. Effects of topically applied rapamycin and mycophenolic acid on TNCB-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Jung KE; Lee YJ; Ryu YH; Kim JE; Kim HS; Kim BJ; Kang H; Park YM
Int Immunopharmacol; 2015 Jun; 26(2):432-8. PubMed ID: 25794646
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus: a review of its use for the management of dermatoses.
Gupta AK; Adamiak A; Chow M
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):100-14. PubMed ID: 12046809
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus clinical studies for atopic dermatitis and other conditions.
Bergman J; Rico MJ
Semin Cutan Med Surg; 2001 Dec; 20(4):250-9. PubMed ID: 11770912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
